WASHINGTON—The Endocrine Society has selected Yoshitomo Hoshino, M.D., Ph.D., as the recipient of its 2025 C. Wayne Bardin, M.D., International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders.
The C. Wayne Bardin, M.D., International Travel Award was created in honor of Past President Wayne Bardin, who made remarkable research contributions to both reproductive physiology and contraception throughout his long career. As the winner, Hoshino received a $3,000 travel grant for ENDO and complimentary meeting registration.
Hoshino is a physician-scientist in the Department of Nephrology and Endocrinology at The University of Tokyo Hospital in Tokyo, Japan. After gaining broad clinical experience in endocrinology, he pursued research and earned his Ph.D. in Internal Medicine from the University of Tokyo, where his work focused on bone and mineral metabolism.
Hoshino identified a novel autoimmune mechanism in acquired FGF23-related hypophosphatemic osteomalacia and proposed the disease concept of “autoimmune osteomalacia,” a discovery published in The New England Journal of Medicine. He is passionate about bridging clinical observation and basic research, leveraging his clinical background to contribute to the development of new diagnostic and therapeutic strategies in endocrinology.
Additional information about these awards can be found at: https://www.endocrine.org/awards/c-wayne-bardin-md-international-travel-award.
# # #
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.
News Release